Ruane, Cunniff & Goldfarb’s Dentsply Sirona XRAY Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,018	Closed	-$234K	–	41
2019 Q2	$234K	Buy	+4,018	New	+$216K	﹤0.01%	34
2019 Q1	–	Sell	-7,610	Closed	-$283K	–	58
2018 Q4	$283K	Sell	7,610 -21,770	-74%	-$792K	﹤0.01%	55
2018 Q3	$1.11M	Buy	29,380 +139	+0.5%	+$5.79K	0.01%	50
2018 Q2	$1.28M	Sell	29,241 -9,611	-25%	-$451K	0.01%	52
2018 Q1	$1.94M	Sell	38,852 -8,812,022	-100%	-$519M	0.02%	45
2017 Q4	$583M	Sell	8,850,874 -39,781	-0.4%	-$2.53M	4.78%	6
2017 Q3	$532M	Buy	8,890,655 +40,767	+0.5%	+$2.42M	4.66%	8
2017 Q2	$574M	Buy	8,849,888 +128,651	+1%	+$8.13M	5.31%	5
2017 Q1	$545M	Sell	8,721,237 -381,477	-4%	-$23M	5.14%	4
2016 Q4	$526M	Buy	9,102,714 +939,312	+12%	+$55.5M	4.94%	5
2016 Q3	$485M	Buy	8,163,402 +3,458,153	+73%	+$212M	4.56%	7
2016 Q2	$292M	Sell	4,705,249 -138,075	-3%	-$8.5M	2.78%	11
2016 Q1	$298M	Buy	+4,843,324	New	+$285M	2.32%	12

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's XRAY Position: Q3 2019 in Review

Ruane, Cunniff & Goldfarb sold out of Dentsply Sirona (XRAY) in Q3 2019, closing a stake of 4,018 shares — an estimated $234K sold.

Ruane, Cunniff & Goldfarb first reported a position in XRAY in Q1 2016 and held it in 13 quarters. The position peaked at $583M in Q4 2017. 532 funds tracked by Wall St. Rank hold XRAY as of Q3 2019.

Ruane, Cunniff & Goldfarb reported no remaining Dentsply Sirona position as of Q3 2019 after selling out during the quarter.
Ruane, Cunniff & Goldfarb sold 4,018 Dentsply Sirona shares in Q3 2019, an estimated $234K.
Ruane, Cunniff & Goldfarb first reported a position in Dentsply Sirona in Q1 2016 and held it in 13 quarters.
Ruane, Cunniff & Goldfarb's Dentsply Sirona position peaked at $583M in Q4 2017.
532 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2019.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q3 2019, filed 14 Nov 2019.